MedPath

Slow Digestible Carbohydrates and Exercise in Adolescents With Type 1 Diabetes

Not Applicable
Active, not recruiting
Conditions
Type 1 Diabetes
Hypoglycemia
Interventions
Dietary Supplement: super starch
Dietary Supplement: maltodextrin
Registration Number
NCT05540132
Lead Sponsor
State University of New York at Buffalo
Brief Summary

In this within-subject cross-over study, the investigators hypothesize that corn-starch based supplements taken prior to exercise will decrease the risk of delayed hypoglycemia in adolescents with T1D, improve performance during exercise, and decrease glycemic variability during exercise.

Detailed Description

Type 1 diabetes (T1D), one of the most common chronic diseases in adolescents, is caused by the destruction of insulin producing beta cells which are located in the pancreas. There are many factors that impact diabetes control which are insulin administration, intake of food and exercise. When an individual exercises, weight is better managed which allows for a better cardiovascular system. Exercising also improves insulin sensitivity which can increased the risk for delayed hypoglycemia (low blood sugar). Many individuals with T1D do not participate (or under-participate) in exercise due to the fear of hypoglycemia. This study will recruit adolescents with Type 1 diabetes to undergo a maximal exercise test to determine their VO2max. Study participants then will complete 2 exercise performance tests prior to which the participant will be randomized to consume 22 grams of either fast acting carbohydrates or long-acting cornstarch based supplements. Subjects will be asked to bike for 45 minutes (at 50% of VO2max) and then complete a 3.75 mile bike ride as quickly as possible. The investigators will document the time to completion of the bike ride as well as monitor glucose levels via continuous glucose monitoring for 12 hours after completion of the exercise test.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Age 12 - <18 year old male and female subjects with Type 1 diabetes for > 1 year
  • HbA1c <10.5%
  • Body Mass Index >10th % and <95th%
  • Not being treated with sensor-augmented pump therapy
  • Ability to participate in exercise activity - biking
  • Willing to wear a continuous glucose monitor (CGM) sensor
Exclusion Criteria
  • Severe hypoglycemia (requiring glucagon or external assistance) in last 6 months
  • Admission for diabetic ketoacidosis in last 3 months
  • History of chronic lung disease, congenital heart disease or chronic asthma
  • Food (including corn)/dye allergies
  • Other chronic medical conditions except for well-controlled thyroid disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Slow-acting cornstarch supplementsuper starchPrior to exercise performance test, subject will be randomized to consume 22 grams of slow-acting cornstarch based supplement or fast-acting carbohydrate (maltodextrin)
Fast Acting CarbohydratemaltodextrinPrior to exercise performance test, subject will be randomized to consume 22 grams of fast-acting carbohydrate (maltodextrin) or slow-acting cornstarch based supplement
Primary Outcome Measures
NameTimeMethod
Glycemic variability during exercise challengeDuring exercise challenge

Review of continuous glucose monitoring data

Time to completion of distance bike challengeDuring exercise challenge

Number of minutes to complete 3.75 mile bike ride

Number of hypoglycemic events 12 hours after completion of exercise challenge12 hours after exercise challenge

Review of continuous glucose monitoring data

Secondary Outcome Measures
NameTimeMethod
Percent time spent in hypoglycemia following exercise challenge12 hours after exercise challenge

Review of continuous glucose monitoring data

Percent time above range, in range, and below range following exercise challenge12 hours after exercise challenge

Review of continuous glucose monitoring data

Glycemic variability in the 12 hours following the exercise test12 hours after exercise challenge

Review of continuous glucose monitoring data

Trial Locations

Locations (1)

UB MD Pediatrics Division of Pediatric Endocrinology

🇺🇸

Buffalo, New York, United States

© Copyright 2025. All Rights Reserved by MedPath